MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$28.02
+0.04 (+0.14%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-27.75%
YTD
-21.53%
Open$27.77
Previous Close$27.98
Day High$28.13
Day Low$27.38
52W High$47.65
52W Low$22.30
Volume—
Avg Volume1.46M
Market Cap2.45B
P/E Ratio—
EPS$-4.24
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.44
Below
SMA 200
$27.93
Above
RSI (14)
35
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+232.6% upside
Current
$28.02
$28.02
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.96 | -0.02% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $385.65 | +1.55% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.11 | -0.52% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $508.34 | -1.55% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $784.85 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $239.56 | -2.42% | 40.0 | 32.33B |